Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

of Actavis Group. 

Actavis Specialty Brands R&D investment in the fourth quarter increased $23.8 million due to higher in-licensing costs and increased costs related to our biosimilar product development.  Actavis Specialty Brands selling and marketing expenses decreased by $1.2 million to $45.3 million in the fourth quarter, primarily due to lower promotional spending in the U.S., partially offset by higher commercial spending in Canada.

For the full year 2012, Actavis Specialty Brands segment net revenue increased 9 percent to $482.4 million, due to increased sales of Generess Fe® which was launched in the second quarter of 2011 and sales growth for key promoted products including  Rapaflo® and Crinone® and the addition of  Kadian®.

Actavis Specialty Brands segment adjusted gross margin for the full year 2012 was 76.1 percent, compared to 78.7 percent in 2011 as a result of product mix. Anda Distribution Segment InformationThree Months EndedTwelve Months EndedDecember 31, December 31,(Unaudited; $ in millions)2012201120122011Net revenue

$
203.9$
251.4$
986.4$
776.2Operating expenses:Cost of sales

168.1214.6846.6652.7Selling and marketing

21.320.889.877.2Segment contribution

$
4.5$
.0$
50.0$
46.3Segment margin

7.1%6.4%5.1%6.0%Gross profit

$
35.8$
36.8$
39.8$
23.5Gross margin

17.6%14.6%14.2%15.9%Anda Distribution segment net revenue for the fourth quarter 2012 decreased 19 percent to $203.9 million compared to $251.4 million in the fourth quarter 2011 due to lower chain sales offset by new product launches. Anda Distribution segment revenue consists only of sales of third-party products and excludes sales of Actavis' brand and generic products.

Anda Distribution segment gross margin increased 300 basis points to 17.6 percent in the fourth quarter 2012, prim
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
11. Aethlon Medical Note: Fiscal Year Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Apr. 16, 2015 Research and Markets ... "Corporate Reputation of Pharma in 2014 - a ... report to their offering. For the ... on the corporate reputation of the pharmaceutical industry held ... with the views of patient organisations representing all therapy ...
(Date:4/16/2015)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... commercialization of products for the treatment of central nervous ... the first quarter of 2015 on Wednesday, May 6, ... Company will host a conference call at 4:30 PM ... management will discuss the first quarter 2015 financial results ...
(Date:4/16/2015)...  Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) will report ... Wednesday, May 6, 2015, following the close of the U.S. ... call and live webcast on the same day at 5:00 ... the financial results.  To access the webcast ... "Investors" link.  Please log onto the webcast prior to the ...
Breaking Medicine Technology:Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3
... 2011 Unilife Corporation ("Unilife" or the "Company") (Nasdaq: ... be presenting at Cowen and Company,s 31st Annual Health Care ... Boston. Alan Shortall, Chief Executive Officer of Unilife, is scheduled ... 2011. The conference presentation will be broadcast over ...
... VICTOR, N.Y., March 7, 2011 PharmaNova, Inc. ... whereby Lacerta Bio,s experienced team of business development ... and U.K. to support its 2011 business growth ... PharmaNova,s partnering base for its innovative, nanoparticle technology, ...
Cached Medicine Technology:Unilife to Present at the 31st Annual Cowen Health Care Conference on Wednesday, March 9, 2011 in Boston 2PharmaNova Fuels Business Growth with Lacerta Bio Partnership 2
(Date:4/18/2015)... Lowcostcarinsuranceprice.com has released a new blog post explaining the ... prices . , Drivers who live in states ... to pay more for auto insurance plans that provide ... offer protection against vehicle theft. , Affordable auto ... single website: http://lowcostcarinsuranceprice.com/ . Drivers who own ...
(Date:4/18/2015)... More than 2000 styles of newly designed prom ... online store carrying celebrity inspired special occasion dresses. With ... perfect dresses for their prom. For those who are ... TheCelebrityDresses.com would be an ideal choice. , "We ... inspired by the most loved styles seen at this ...
(Date:4/18/2015)... 2015 French physician and gastronome Anthelme ... when he uttered, “Tell me what you eat, and ... to cope with stress or sadness has often been ... indicates otherwise. Data collected from their Emotional Eating ... emotional eating, but for different reasons. , Collecting data ...
(Date:4/17/2015)... California (PRWEB) April 17, 2015 ... Dr. Kevin Sadati of the Gallery of ... Orange County’s top beauty experts. The publication focused ... lift, facial stem cell fat grafting, eyelid surgery, laser ... facial plastic surgery has resulted in thousands ...
(Date:4/17/2015)... In Defense of Christians (IDC) Executive Director ... April 15th, the European Parliament joined its voice with ... Armenian Genocide, “paying tribute, on the eve of the ... Armenian victims who perished in the Ottoman Empire.” ... this timely and needed recognition of a tragic episode ...
Breaking Medicine News(10 mins):Health News:High Rates Of Car Theft Can Have An Impact on Auto Insurance Prices! 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3
... 21st century mums are more likely,to turn to the ... less judged on their parenting skills than in other environments,new ... found that only 2% of mothers felt,judged by their online ... and other mums at the school gate. The findings mark ...
... 19 CorVel Corporation,(Nasdaq: CRVL ) today ... common stock under the stock repurchase program previously ... 2006, the Board had approved a,1,500,000 share expansion ... Company has repurchased 862,323 shares, with a remaining ...
... A pilot study from researchers at ... band imaging (NBI) colonoscopy used in cancer surveillance ... lesions. The research appears in the November issue ... of the American Society for Gastrointestinal Endoscopy. , ...
... 90% of people miss out on critical early treatment period, ... call them transient ischemic attacks, but they,re more commonly known ... be deadly. , What,s worse, many people who suffer such ... people who experienced symptoms of a transient ischemic attack (TIA) ...
... join Congressmen Ciro D. Rodriguez, Charlie Gonzalez, Henry ... Children,s Health,Insurance Program (SCHIP) bill that will provide ... Nancy Pelosi Congressman Ciro D. Rodriguez (TX-23) ... Cuellar (TX-28), WHAT: Rally for Children,s Health ...
... Improved Patient Privacy,Protections, LOS ANGELES, Nov. 16 ... Medical Association (AMA) for,recently updating its HIV testing ... improved protection of patient privacy. According,to a news ... Report, the,AMA,s new guidelines call for, "...physicians to ...
Cached Medicine News:Health News:Mums Go Online to Avoid Judgement 2Health News:CorVel Corporation Announces Resumption of Stock Repurchases 2Health News:CorVel Corporation Announces Resumption of Stock Repurchases 3Health News:Narrow band imaging colonoscopy identifies flat dysplastic lesions in ulcerative colitis patients 2Health News:Narrow band imaging colonoscopy identifies flat dysplastic lesions in ulcerative colitis patients 3Health News:Mini Strokes: Major Health Threats 2Health News:Mini Strokes: Major Health Threats 3Health News:AMA's New HIV Testing Guidelines Good for Public Health, Says AHF 2
The RU is a low profile implantable bipolar tined permanent pacing lead for stimulation of either the atrium (J model) or the ventricle (straight model)....
The Petite leads are low profile (4.8F lead body diameter) implantable endocardial pacing leads which are manufactured using a new proprietary hexafilar coil for permanent stimulation of the ventricl...
The Vitatron Excellence S+ lead series are endocardial leads providing excellent reliability and optimal pacing characteristics....
... Impulse II lead series are silicon ... extend the longevity of the pacemaker ... The high impedance of the lead ... electrode surface, combined with the elution ...
Medicine Products: